CSIMarket
 
Rasna Therapeutics Inc.  (ATVM)
Other Ticker:  
 
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 69
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -0
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Rasna Therapeutics Inc.


 

Unilever N V

Sales and Earnings Unchanged

In the second quarter Unilever N V eps of $1.28 per share compare to $0.00 a year ago and eps dropped by -67.24 % from $3.90 per share from the previous quarter.

Sales remained unchanged to $29.26 billions from $0.00 millions in the same quarter a year ago and sequentially Sales Tumbled by -48.75 % from $57.10 billions.

Unilever Plc

Unilever Plc announced second quarter operating income of $5139.68 millions

In the second quarter Unilever Plc eps of $1.28 per share compare to $0.00 a year ago and eps dropped by -67.24 % from $3.90 per share from the previous quarter.

Sales remained unchanged to $29.26 billions from $0.00 millions in the same quarter a year ago and sequentially Sales Tumbled by -48.75 % from $57.10 billions.

Frelii, Inc.

Losses Widen but Revenues Unchanged

In the second quarter Frelii, Inc increased losses of $-0.04 per share compare to $-0.03 a year ago and eps fell from $0.32 per share from the previous quarter.

Sales remained unchanged to $0.02 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Toronto Dominion Bank

Toronto Dominion Bank announced third quarter operating profit of $3110.726 millions

In the third quarter Toronto Dominion Bank eps of $1.33 per share compare to $0.00 a year ago and income improved by 2.35 % from $1.30 per share from the previous quarter.

Revenues remained unchanged to $8.04 billions from $0.00 millions in the same quarter a year ago and sequentially Revenues increased by 2.65 % from $7.83 billions.

Akari Therapeutics Plc

Akari Therapeutics Plc announced second quarter operating shortfall of $-6.031447 millions

In the second quarter Akari Therapeutics Plc reached break-even of $0.00 per share compare to $-0.17 a year ago and from $-0.03 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.






   
Major Competitors Stock performance

5 Days Decrease / Increase
     
• View Complete Report
   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SGBY's Profile

Stock Price

SGBY's Financials

Business Description

Fundamentals

Charts & Quotes

SGBY's News

Suppliers

SGBY's Competitors

Customers & Markets

Economic Indicators

SGBY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071